Back to the full story1 source · STAT+: GSK lays out plans to cut costs, pursue more late-stage drug trials◆ Timeline
STAT+: GSK lays out plans to cut costs, pursue more late-stage drug trials
1 report in the order each was filed. Tap any entry to open that report at its source.